HIF1A and B-cell chronic lymphocytic leukemia: The interaction with stromal cells (SC) induces HIF-1α in CLL cells, through an increased activity of the RAS/ERK1-2, RHOA/RHOA kinase and PI3K/AKT pathways, contributing to drug resistance mechanisms, leukemia survival and tumor propagation [6,7,8].